ZCCHC13
gene geneOn this page
Also known as 4930513O09RIKCnbp2ZNF9L
Summary
ZCCHC13 (zinc finger CCHC-type containing 13, HGNC:31749) is a protein-coding gene on chromosome Xq13.2, encoding Zinc finger CCHC domain-containing protein 13 (Q8WW36).
This gene appears to represent an intronless retrocopy of a related multi-exon gene located on chromosome 3. However, the CDS of this intronless gene remains relatively intact, it is conserved in other mammalian species, it is known to be transcribed, and it is therefore thought to encode a functional protein. The encoded protein contains six CCHC-type zinc fingers, and is thus thought to function as a transcription factor.
Source: NCBI Gene 389874 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 26 total
- MANE Select transcript:
NM_203303
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31749 |
| Approved symbol | ZCCHC13 |
| Name | zinc finger CCHC-type containing 13 |
| Location | Xq13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | 4930513O09RIK, Cnbp2, ZNF9L |
| Ensembl gene | ENSG00000187969 |
| Ensembl biotype | protein_coding |
| OMIM | 301125 |
| Entrez | 389874 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000339534
RefSeq mRNA: 1 — MANE Select: NM_203303
NM_203303
CCDS: CCDS14425
Canonical transcript exons
ENST00000339534 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001374013 | 74304180 | 74305034 |
Expression profiles
Bgee: expression breadth broad, 11 present calls, max score 84.34.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0335 / max 31.1249, expressed in 3 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196756 | 0.0192 | 3 |
| 196755 | 0.0143 | 3 |
Top tissues by expression
232 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.34 | gold quality |
| left testis | UBERON:0004533 | 83.33 | gold quality |
| right testis | UBERON:0004534 | 81.17 | gold quality |
| testis | UBERON:0000473 | 80.25 | gold quality |
| buccal mucosa cell | CL:0002336 | 59.77 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 48.11 | gold quality |
| adult organism | UBERON:0007023 | 46.78 | gold quality |
| deltoid | UBERON:0001476 | 45.91 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| vastus lateralis | UBERON:0001379 | 42.42 | gold quality |
| quadriceps femoris | UBERON:0001377 | 42.35 | gold quality |
| biceps brachii | UBERON:0001507 | 42.15 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.77 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 41.49 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| oviduct epithelium | UBERON:0004804 | 41.21 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 41.14 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting ZCCHC13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-369-3P | 99.85 | 70.52 | 2264 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-4472 | 99.56 | 66.08 | 1478 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-7109-5P | 99.18 | 66.13 | 1057 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-6749-3P | 99.00 | 65.73 | 1443 |
| HSA-MIR-6877-3P | 98.98 | 65.83 | 560 |
| HSA-MIR-6819-3P | 98.95 | 65.57 | 572 |
| HSA-MIR-3124-3P | 98.87 | 68.95 | 2123 |
| HSA-MIR-6885-5P | 98.71 | 64.33 | 902 |
| HSA-MIR-6887-5P | 98.56 | 68.49 | 1295 |
| HSA-MIR-6795-5P | 98.52 | 68.51 | 1277 |
| HSA-MIR-4691-5P | 98.41 | 66.77 | 1343 |
| HSA-MIR-6792-3P | 98.41 | 66.86 | 1359 |
Literature-anchored findings (GeneRIF, showing 1)
- ZCCHC13 functions an oncogene for hepatocellular carcinoma, and DNA hypomethylation is a driving factor in carcinogenesis. (PMID:30940166)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cnbpa | ENSDARG00000045776 |
| danio_rerio | cnbpb | ENSDARG00000070922 |
| mus_musculus | Zcchc13 | ENSMUSG00000031330 |
| rattus_norvegicus | Zcchc13 | ENSRNOG00000002923 |
| drosophila_melanogaster | CNBP | FBGN0034802 |
| caenorhabditis_elegans | WBGENE00019537 |
Paralogs (3): ZCCHC9 (ENSG00000131732), ZCCHC7 (ENSG00000147905), CNBP (ENSG00000169714)
Protein
Protein identifiers
Zinc finger CCHC domain-containing protein 13 — Q8WW36 (reviewed: Q8WW36)
All UniProt accessions (1): Q8WW36
RefSeq proteins (1): NP_976048* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001878 | Znf_CCHC | Domain |
| IPR036875 | Znf_CCHC_sf | Homologous_superfamily |
Pfam: PF00098
UniProt features (7 total): zinc finger region 6, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WW36-F1 | 66.67 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 46 (showing top):
GOBP_CYTOPLASMIC_TRANSLATION, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSLATION_REGULATOR_ACTIVITY, GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATION, GOBP_POSITIVE_REGULATION_OF_TRANSLATION, GOBP_REGULATION_OF_TRANSLATION, TAATTA_CHX10_01, GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS, GOMF_MRNA_BINDING, GOMF_SINGLE_STRANDED_RNA_BINDING, GOBP_REGULATION_OF_PROTEIN_METABOLIC_PROCESS, MIKKELSEN_ES_ICP_WITH_H3K4ME3, chrXq13, GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION
GO Biological Process (1): positive regulation of cytoplasmic translation (GO:2000767)
GO Molecular Function (7): single-stranded RNA binding (GO:0003727), mRNA binding (GO:0003729), zinc ion binding (GO:0008270), translation regulator activity (GO:0045182), nucleic acid binding (GO:0003676), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA binding | 2 |
| binding | 2 |
| cytoplasmic translation | 1 |
| positive regulation of translation | 1 |
| regulation of cytoplasmic translation | 1 |
| transition metal ion binding | 1 |
| molecular_function | 1 |
| regulation of translation | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1150 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZCCHC13 | DMPK | Q09013 | 581 |
| ZCCHC13 | CHIC1 | Q5VXU3 | 519 |
| ZCCHC13 | MBNL1 | Q9NR56 | 495 |
| ZCCHC13 | MBNL2 | Q5VZF2 | 434 |
| ZCCHC13 | MBNL3 | Q9NUK0 | 433 |
| ZCCHC13 | FAM47B | Q8NA70 | 411 |
| ZCCHC13 | NME2 | P22392 | 409 |
| ZCCHC13 | HNRNPK | P61978 | 408 |
| ZCCHC13 | SATL1 | Q86VE3 | 402 |
| ZCCHC13 | ZCCHC9 | Q8N567 | 397 |
| ZCCHC13 | RLIM | Q9NVW2 | 396 |
| ZCCHC13 | LARP1B | Q659C4 | 387 |
| ZCCHC13 | SLC16A2 | P36021 | 380 |
| ZCCHC13 | NUCLEOLIN | P19338 | 360 |
| ZCCHC13 | CLCN1 | P35523 | 348 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SIAH1 | ZCCHC13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZCCHC13 | SIAH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF648 | ZCCHC13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNRPA | ZCCHC13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF250 | ZCCHC13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZCCHC13 | GUCD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF648 | ZCCHC13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GUCD1 | ZCCHC13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SNRPA | ZCCHC13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF250 | ZCCHC13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZCCHC13 | ATXN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): ZCCHC13 (Two-hybrid), ZCCHC13 (Two-hybrid), ZCCHC13 (Two-hybrid), ZCCHC13 (Two-hybrid), ZNF250 (Two-hybrid), ZCCHC13 (Two-hybrid)
ESM2 similar proteins: A8WLV5, E0X9N4, O42395, O65639, P09052, P24346, P34689, P36627, P53849, P53996, P62633, P62634, P91599, P92186, Q04832, Q09476, Q0JD07, Q18034, Q3MSQ8, Q3T0Q6, Q4JG17, Q4R5S7, Q54NW4, Q5NU13, Q5R5R5, Q5W5U4, Q5ZA07, Q61496, Q64060, Q67YE6, Q6GWX0, Q6IDS6, Q7F8R0, Q7XPK1, Q84MZ4, Q8T8R1, Q8VZ42, Q8WW36, Q91372, Q94C69
Diamond homologs: O42395, P53996, P62633, P62634, Q3T0Q6, Q5R5R5, Q8RWN5, Q8WW36
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 2 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
260 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:74304402:A:AG | acceptor_gain | 0.9100 |
| X:74304455:C:A | acceptor_gain | 0.9000 |
| X:74304274:G:GG | donor_gain | 0.8800 |
| X:74304456:G:A | acceptor_gain | 0.8700 |
| X:74304271:GCA:G | donor_gain | 0.8600 |
| X:74304462:ATCT:A | acceptor_gain | 0.8000 |
| X:74304416:T:TA | acceptor_gain | 0.7800 |
| X:74304463:T:G | acceptor_gain | 0.7800 |
| X:74304462:A:AG | acceptor_gain | 0.7500 |
| X:74304403:C:G | acceptor_gain | 0.7400 |
| X:74304269:GAGCA:G | donor_gain | 0.7200 |
| X:74304371:TTCTC:T | donor_gain | 0.7200 |
| X:74304400:A:AG | acceptor_gain | 0.7200 |
| X:74304465:T:TA | acceptor_gain | 0.7200 |
| X:74304411:T:A | acceptor_gain | 0.6800 |
| X:74304401:C:G | acceptor_gain | 0.6700 |
| X:74304402:ACCT:A | acceptor_gain | 0.6700 |
| X:74304505:G:GG | donor_gain | 0.6700 |
| X:74304353:TGG:T | donor_gain | 0.6600 |
| X:74304354:G:GA | donor_gain | 0.6600 |
| X:74304405:T:TA | acceptor_gain | 0.6400 |
| X:74304510:GATCC:G | donor_gain | 0.6400 |
| X:74304415:GTG:G | donor_gain | 0.6300 |
| X:74304414:T:A | acceptor_gain | 0.5900 |
| X:74304754:G:GT | donor_gain | 0.5900 |
| X:74304755:A:T | donor_gain | 0.5900 |
| X:74304279:G:GT | donor_gain | 0.5800 |
| X:74304381:G:GA | donor_gain | 0.5800 |
| X:74304501:GACT:G | donor_gain | 0.5800 |
| X:74304476:T:TA | acceptor_gain | 0.5700 |
AlphaMissense
1074 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:74304626:C:A | H120Q | 0.761 |
| X:74304626:C:G | H120Q | 0.761 |
| X:74304563:T:A | H99Q | 0.732 |
| X:74304563:T:G | H99Q | 0.732 |
| X:74304635:A:C | K123N | 0.715 |
| X:74304635:A:T | K123N | 0.715 |
| X:74304680:C:A | H138Q | 0.693 |
| X:74304680:C:G | H138Q | 0.693 |
| X:74304685:C:A | A140D | 0.683 |
| X:74304634:A:T | K123I | 0.678 |
| X:74304632:G:C | Q122H | 0.676 |
| X:74304632:G:T | Q122H | 0.676 |
| X:74304491:C:A | H75Q | 0.659 |
| X:74304491:C:G | H75Q | 0.659 |
| X:74304653:G:C | K129N | 0.639 |
| X:74304653:G:T | K129N | 0.639 |
| X:74304657:T:G | Y131D | 0.636 |
| X:74304500:A:C | K78N | 0.627 |
| X:74304500:A:T | K78N | 0.627 |
| X:74304600:T:A | C112S | 0.627 |
| X:74304601:G:C | C112S | 0.627 |
| X:74304561:C:G | H99D | 0.624 |
| X:74304609:T:A | C115S | 0.615 |
| X:74304610:G:C | C115S | 0.615 |
| X:74304613:G:T | G116V | 0.611 |
| X:74304654:T:A | C130S | 0.611 |
| X:74304655:G:C | C130S | 0.611 |
| X:74304539:T:G | C91W | 0.609 |
| X:74304496:C:A | A77D | 0.599 |
| X:74304667:G:T | G134V | 0.589 |
dbSNP variants (sampled 300 via entrez): RS1001564499 (X:74304357 G>A,C), RS1002266041 (X:74304903 T>C), RS1002298592 (X:74305465 G>A), RS1004406889 (X:74303979 A>C), RS1007231326 (X:74303420 G>C), RS1007283764 (X:74302969 T>C), RS1011123525 (X:74302772 C>A), RS1013344269 (X:74302366 A>C), RS1013375357 (X:74302766 G>A,T), RS1015176551 (X:74303088 A>G), RS1015928630 (X:74304967 C>T), RS1017354062 (X:74303035 A>G), RS1019322308 (X:74303586 A>C), RS1026543666 (X:74304180 A>T), RS1026687578 (X:74302428 A>G)
Disease associations
OMIM: gene MIM:301125 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| clothianidin | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Rifampin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.